Aurobindo

Financial

Investors

Contact Person

Unaudited Quarterly Results for the First Quarter ended 30th June, 2005

(Rs.in Mio)

	First Quarter Ended		Year ended
Particulars	30.06.2005	30.06.2004	31.03.2005
	(Unaudited)	(Unaudited)	(Audited)
Net Sales/Income from Operations	2806.6	2849.3	11591.7
Other Income	35.8	23.6	165.6
Total Income	2842.4	2872.9	11757.3
Expenditure
a. (Increase) / Decrease in Stock in Trade	(124.5)	(234.6)	(132.4)
b. Consumption of Raw Materials	1813.9	1710.9	6574.4
c. Staff Cost	182.9	159.5	662.3
d. Other Expenditure	703.8	816.7	3419.1
Total expenditure	2576.1	2452.5	10523.4
Profit Before Depreciation, Interest & Tax	266.3	420.4	1233.9
Interest	134.4	73.6	379.9
Depreciation	118.7	109.8	404.9
Profit before taxation	13.2	237.0	429.1
Provision for Taxation
a. Current Tax	1.7	17.8	40.1
b. Deferred Tax	(9.2)	38.7	38.8
c. Fringe Benefit Tax	0.6	0	0
d. Tax adjustments of previous years	0	0.3	(0.5)
Net Profit	20.1	180.2	350.7
Paid-up Equity Share Capital	253.9	253.9	253.9
(Face value Rs. 5 per share)
Reserves excluding Revaluation Reserves	-	-	7632.0
Earnings per share - Not annualised
Basic (Rs.)	0.39	3.55	6.91
Diluted (Rs.)	0.39	3.55	6.91
Aggregate of Non-promoters Shareholding
a. Number of Shares	22933456	22938206	229391.56
b. Percentage of Shareholding	45.17	45.18	45.18

Notes:
1.	The above unaudited results which are subjected to limited review by the Auditors of the Company, were reviewed by the Audit Committee and have been taken on record by the Board at its meeting held on 31.07.2005.
2.	The Company's operations fall within a single primary business segment viz. 'Pharmaceutical Products'.
3.	Investor complaints pending at the beginning of the quarter: Nil, received: 50, resolved: 50 and lying unresolved at the end of the quarter: Nil.
4.	Sales for the quarter include exports of Rs.1585.3 million (Rs.1294.5 million).
5.	Figures for the previous quarter have been rearranged wherever necessary.